Actinium Pharmaceuticals Inc (ATNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,707 | 5,533 | 5,619 | 5,704 | 0 |
| Receivables | N/A | N/A | N/A | 238 | N/A |
| Other current assets | 0 | 0 | 0 | 252 | 0 |
| TOTAL | $7,407 | $5,752 | $5,786 | $6,199 | $0 |
| Non-Current Assets | |||||
| PPE Net | 128 | 14 | 3 | 1 | N/A |
| Other Non-Current Assets | 35 | 0 | 0 | 0 | 0 |
| TOTAL | $162 | $14 | $3 | $1 | $N/A |
| Total Assets | $7,569 | $5,766 | $5,789 | $6,201 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 124 | N/A |
| Accounts payable and accrued liabilities | 2,498 | 460 | 928 | 645 | 14 |
| Accrued Expenses | N/A | N/A | N/A | N/A | 22 |
| Other current liabilities | 6,710 | 6,707 | 3,575 | 4,440 | N/A |
| TOTAL | $9,492 | $7,325 | $4,643 | $5,209 | $95 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $9,492 | $7,325 | $4,643 | $5,209 | $95 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,182 | 843 | N/A | N/A | N/A |
| Common Shares | 30 | 25 | 21 | 137 | 112 |
| Retained earnings | -91,205 | -66,517 | -55,744 | -47,382 | -270 |
| TOTAL | $-1,923 | $-1,560 | $1,146 | $992 | $-95 |
| Total Liabilities And Equity | $7,569 | $5,766 | $5,789 | $6,201 | $0 |